AUSTIN, Texas, June 1 /PRNewswire-FirstCall/ -- Spinal Concepts, Inc., an Abbott Laboratories company, today announced the launch of its Nex-Link(TM) implant system, a system of implants and instruments for posterior cervicothoracic spinal fixation. Nex-Link is designed for use in patients with serious complications due to injury, trauma or degeneration in the upper section of the spine.
"Nex-Link enables the surgeon to provide immediate posterior stability to the patient's spinal column following decompression or the development of traumatic spinal instability," said Christopher Sturm, M.D., medical director of the Mercy Regional Neurosurgery Center in Janesville, Wis., who was the first surgeon to implant Nex-Link following its clearance by the U.S. Food and Drug Administration. "The modularity of the Nex-Link system enables the surgeon to address the patient's anatomy in normal as well as in challenging procedures."
"Nex-Link provides even more depth to Spinal Concepts' line of cervical implants," said Jeff Binder, president of Spinal Concepts. "This product demonstrates our continued commitment to posterior cervical fixation -- one of the core segments of spinal fixation." The posterior cervical fixation market is estimated at $77 million and is growing at an annual rate of greater than 15 percent.
About Spinal Concepts
Spinal Concepts, a leading innovator of spinal implant technology, understands that spine surgeons value device simplicity. Spinal Concepts is recognized for providing simplicity through innovative engineering. Spinal Concepts' patented technology, intuitive implants and instruments, and knowledgeable sales representatives make it easier and more efficient for the operating team to prepare and implant spinal devices. Spinal Concepts was acquired by Abbott Laboratories in June 2003. For more information, visit the company's Web site at http://www.spinalconcepts.com/ .
About Abbott Laboratories
Abbott Laboratories is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 55,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com/ .
CONTACT: Media, Kelly Carper Erickson, +1-512-533-1048, or+1-512-413-5935 (mobile), or Financial Community, Christy Wistar,+1-847-938-4475, both of Abbott Laboratories